)
Edge12 Jun 2026
Set in Stone: The Story of Richemont
From a South African tobacco company to Cartier, a deep dive into how Richemont built one of the world's leading hard luxury empires.
Pulmatrix
Pulmatrix (PULM) investor relations material
Pulmatrix Registration filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Registration filing summary4 Jun, 2026
Company overview and business model
Focuses on developing novel inhaled therapeutics for migraine and respiratory diseases using proprietary iSPERSE™ dry powder technology.
Product pipeline targets CNS disorders (e.g., acute migraine) and serious lung diseases (COPD, ABPA).
iSPERSE™ enables efficient delivery of small and large molecule drugs via inhalation, aiming to improve pharmacokinetics and reduce side effects.
Incorporated in Delaware in 2013; operates as a virtual company with no leased or owned physical space.
Financial performance and metrics
As of May 27, 2026, 3,652,285 shares of common stock were issued and outstanding.
The offering could increase outstanding shares by approximately 13%.
Use of proceeds and capital allocation
Will not receive any proceeds from the resale of shares by the selling stockholder; all proceeds go to the selling stockholder.
Will bear all costs and expenses related to the registration of the shares.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Pulmatrix
- Merger with Eos SENOLYTIX is critical as Q1 net loss narrows and cash reserves remain limited.PULM
Q1 202615 May 2026 - Revenue fell to nil in 2025 as the company pivots to merger and asset monetization strategies.PULMQ4 202526 Feb 2026
- Merger forms a well-funded biotech advancing targeted protein degraders for cancer and pain.PULMM&A Announcement14 Jan 2026
- Virtual meeting to elect directors, ratify auditor, and review governance and executive pay.PULMProxy Filing2 Dec 2025
- Q2 net loss narrowed, revenue fell to zero, and future depends on Cullgen merger approval.PULMQ2 202517 Oct 2025
- Q3 revenue and losses fell, MannKind deal cut costs, and cash runway may last into Q4 2026.PULMQ3 202417 Oct 2025
- Q3 2025 saw zero revenue, lower expenses, and a pending Cullgen merger with cash preservation focus.PULMQ3 202516 Oct 2025
- Net loss widened on asset write-down as cost cuts and MannKind deal extended cash runway.PULMQ2 202413 Jun 2025
- Pulmatrix narrows losses and prepares for a strategic merger with Cullgen in 2025.PULMQ4 20246 Jun 2025
Next Pulmatrix earnings date
Q2 20267 Aug, 2026
Pulmatrix
Next Pulmatrix earnings date
Q2 20267 Aug, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage